May 6, 2015 Media

Forbes: Investing In Drugs That Won't Make Money

Dr. Slingsby, GHIT Fund CEO, was interviewed by Forbes about the GHIT Fund's unique business and governance model to drive forward the discovery and development of new medical tools in the developing world. Dr. Slingsby also mentioned three drivers that impact R&D in the life sciences arena: R&D productivity, regulatory science and market pressures.


For more details, please follow this link.